Exploring the Clinical Benefit of Docetaxel or Enzalutamide after Disease Progression during Abiraterone Acetate and Prednisone Treatment in Men with Metastatic Castration-Resistant Prostate Cancer

Tian Zhang, Mallika S. Dhawan, Patrick Healy, Daniel J. George, Michael R. Harrison, Jorge Oldan, Bennett Chin, Andrew J. Armstrong

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Exploring the Clinical Benefit of Docetaxel or Enzalutamide after Disease Progression during Abiraterone Acetate and Prednisone Treatment in Men with Metastatic Castration-Resistant Prostate Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences